QXO Strikes $17 Billion Deal to Buy TopBuild – Now 2nd Largest Building Products Giant in North America
The deal is expected to close in Q3 2026 and immediately boost earnings.
NOTRELOAD AI
American Airlines Rejects United Merger, Citing Harm to Competition
American Airlines rejected a merger with United, saying it would reduce competition, raise prices, and hurt passengers.
DOJ Prepares Antitrust Lawsuit Against Big Egg Producers Over Price Coordination
DOJ may sue Cal-Maine Foods and Versova for possibly coordinating to keep egg prices high during bird flu shortages.
Cerebras Files for IPO: Nvidia’s AI Chip Rival Goes Public
Cerebras plans a Nasdaq IPO after strong growth, big AI deals, and rising demand for powerful chips competing with Nvidia.
Blue Owl Co-CEOs Remove Share Loans to Ease Stock Pressure
CEOs removed risky share-backed loans, easing fears, as investors worry about private credit and withdrawals.
UBS Sees 6-9% Growth for Amneal: Why the Recent Dip is a Buying Opportunity
UBS starts coverage on Amneal Pharmaceuticals with a Buy rating. Strong specialty growth, Parkinson’s drugs, and attractive entry point after recent selloff.